Literature DB >> 24381644

Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea.

Wallace J Wang1, Sondra Gray2, Cristina Sison3, Sushma Arramraju2, Bijo K John2, Syed A Hussain4, Sang H Kim4, Preeti Mehta4, Moshe Rubin4.   

Abstract

BACKGROUND: The incidence, recurrence, and all-cause mortality rate for Clostridium difficile-associated diarrhea (CDAD) has increased markedly over the past 10 years despite treatment. Low vitamin D levels are known to impair immune responses to infection and are associated with increased mortality. We compared the role of patient comorbidity measured by the Charlson Comorbidity Index (CCI) with vitamin D levels to ascertain whether vitamin D levels were an independent variable affecting the outcome of CDAD or a marker of overall comorbidity.
METHODS: A prospective cohort study studied 62 patients hospitalized between 2008 and 2009 with manifestations of CDAD and a positive C. difficile toxin assay. All patients received standard antibiotics (metronidazole and/or vancomycin). Their status at 30-day follow up was classified as resolved or recurred/expired. Patients' CCI was calculated using their medical history. Logistic regression analysis of variables including 25-hydroxyvitamin D, CCI, age, gender, white blood cell count (WBC), albumin and residence type were performed.
RESULTS: There were 62 patients (43.6% men, 56.4% women) with CDAD; mean age was 75 ± 17 years. At 30-day follow up, 28 (45.2%) expired, 10 (16.1%) had persistent or recurrent diarrhea and 24 (38.7%) resolved. Nonresolution was seen in 38 (61.3%). There was no significant association between 30-day resolution status and CCI, gender, WBC, albumin level or residence type. Two variables were found to be independent predictors of resolution of CDAD: normal vitamin D levels (p = 0.028) and age <70 years (p = 0.024). Subjects with low vitamin D were 4.75 times more likely to fail to resolve CDAD than subjects with normal Vitamin D.
CONCLUSION: In this study, vitamin D level and age are independent predictors of CDAD resolution in hospitalized patients. Low vitamin D levels and age >70 years old are associated with increased likelihood of recurrence. Low vitamin D levels are not a marker of comorbidity or advanced age.

Entities:  

Keywords:  Clostridium difficile enteritis; clostridium difficile diarrhea; hypovitaminosis D; recurrent clostridium difficile; vitamin D

Year:  2014        PMID: 24381644      PMCID: PMC3871280          DOI: 10.1177/1756283X13502838

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  19 in total

Review 1.  How to measure comorbidity. a critical review of available methods.

Authors:  Vincent de Groot; Heleen Beckerman; Gustaaf J Lankhorst; Lex M Bouter
Journal:  J Clin Epidemiol       Date:  2003-03       Impact factor: 6.437

Review 2.  Clostridium difficile--more difficult than ever.

Authors:  Ciarán P Kelly; J Thomas LaMont
Journal:  N Engl J Med       Date:  2008-10-30       Impact factor: 91.245

3.  Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.

Authors:  I Vesteinsdottir; S Gudlaugsdottir; R Einarsdottir; E Kalaitzakis; O Sigurdardottir; E S Bjornsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-23       Impact factor: 3.267

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 5.  Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

Authors:  Margherita T Cantorna; Brett D Mahon
Journal:  Exp Biol Med (Maywood)       Date:  2004-12

6.  A prospective cohort study on hospital mortality due to Clostridium difficile infection.

Authors:  J M Wenisch; D Schmid; G Tucek; H-W Kuo; F Allerberger; V Michl; P Tesik; H Laferl; C Wenisch
Journal:  Infection       Date:  2012-04-17       Impact factor: 3.553

7.  Recurrence of symptoms in Clostridium difficile infection--relapse or reinfection?

Authors:  M H Wilcox; W N Fawley; C D Settle; A Davidson
Journal:  J Hosp Infect       Date:  1998-02       Impact factor: 3.926

8.  Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users.

Authors:  Manuel Sánchez de la Torre; Carmen Torres; Gema Nieto; Salvador Vergara; Antonio José Carrero; Juan Macías; Juan Antonio Pineda; Antonio Caruz; Joan Fibla
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

9.  The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.

Authors:  Judith A O'Brien; Betsy J Lahue; J Jaime Caro; David M Davidson
Journal:  Infect Control Hosp Epidemiol       Date:  2007-10-03       Impact factor: 3.254

10.  Vitamin d deficiency and tuberculosis progression.

Authors:  Najeeha Talat; Sharon Perry; Julie Parsonnet; Ghaffa Dawood; Rabia Hussain
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

View more
  8 in total

Review 1.  Persistent and Recurrent Clostridium difficile Colitis.

Authors:  Shola A Cole; Thomas J Stahl
Journal:  Clin Colon Rectal Surg       Date:  2015-06

2.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

3.  Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases.

Authors:  A N Ananthakrishnan; A Cagan; V S Gainer; S-C Cheng; T Cai; P Szolovits; S Y Shaw; S Churchill; E W Karlson; S N Murphy; I Kohane; K P Liao
Journal:  Aliment Pharmacol Ther       Date:  2014-03-18       Impact factor: 8.171

4.  Vitamin D Deficiency Strongly Predicts Adverse Medical Outcome Across Different Medical Inpatient Populations: Results From a Prospective Study.

Authors:  Lena Graedel; Meret Merker; Susan Felder; Alexander Kutz; Sebastian Haubitz; Lukas Faessler; Martha Kaeslin; Andreas Huber; Beat Mueller; Philipp Schuetz
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 5.  How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?

Authors:  Masoumeh Azimirad; Maryam Noori; Hamideh Raeisi; Abbas Yadegar; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Enrico Bentivegna; Paolo Martelletti; Nicola Petrosillo; Mohammad Reza Zali
Journal:  Front Med (Lausanne)       Date:  2021-12-13

Review 6.  Host and Clostridioides difficile-Response Modulated by Micronutrients and Glutamine: An Overview.

Authors:  Andréa V Loureiro; Maria L L Barbosa; Maria L G S Morais; Ismael P Souza; Letícia S Terceiro; Conceição S Martins; Arkila P R Sousa; Renata F C Leitão; Jae H Shin; Cirle A Warren; Deiziane V S Costa; Gerly A C Brito
Journal:  Front Nutr       Date:  2022-06-20

7.  Serum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection.

Authors:  Dejan Micic; Krishna Rao; Bruno Caetano Trindade; Seth T Walk; Elizabeth Chenoweth; Ruchika Jain; Itishree Trivedi; Kavitha Santhosh; Vincent B Young; David M Aronoff
Journal:  Infect Dis Rep       Date:  2015-09-29

Review 8.  Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Stephanie Sirard; Louis Valiquette
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.